Strategies for reducing sudden cardiac death: application of microvolt T-wave alternans testing in clinical practice

Michael J Mirro1

  • 1Parkview Health System Clinical Research Center, Fort Wayne, Indiana 46805, USA. martha@fwcardio.com

Heart Rhythm
|March 3, 2009
PubMed

Insights

Preventing sudden cardiac death (SCD) is a major public health goal. New strategies combine microvolt T-wave alternans (MTWA) and health information technology (HIT) to identify and manage high-risk patients, especially those with preserved ejection fraction.

Area of Science:

  • Cardiology
  • Public Health
  • Health Informatics

Background:

  • Sudden cardiac death (SCD) poses a significant public health challenge.
  • While reduced left ventricular ejection fraction (LVEF) is a known risk factor, identifying high-risk patients with preserved LVEF remains difficult.

Purpose of the Study:

  • To outline strategies for identifying and managing patients at high risk of SCD.
  • To explore the integration of noninvasive risk stratification and health information technology (HIT) in community practice.

Main Methods:

  • Implementation of microvolt T-wave alternans (MTWA) for noninvasive risk stratification.
  • Utilization of health information technology (HIT) for electronic decision support and guideline adherence.
  • Development of a care process for post-myocardial infarction and heart failure patients.

Main Results:

  • HIT facilitates LVEF measurement and optimal pharmacologic therapy.
  • Electronic alerts support adherence to cardiovascular practice guidelines.
  • A structured care process aids in SCD prevention for vulnerable patient groups.

Conclusions:

  • Integrating MTWA and HIT offers a promising approach to capture high-risk patients for SCD prevention.
  • Implementing these strategies in community practice can potentially reduce the burden of SCD.
  • Enhanced patient and physician education supports comprehensive SCD prevention efforts.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...